Your browser doesn't support javascript.
loading
High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.
Biol Blood Marrow Transplant ; 18(5): 788-93, 2012 May.
Article in En | MEDLINE | ID: mdl-22005647

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Combined Modality Therapy / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Antibodies, Monoclonal, Murine-Derived Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2012 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Combined Modality Therapy / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Antibodies, Monoclonal, Murine-Derived Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2012 Document type: Article Affiliation country: France Country of publication: United States